Log in to save to my catalogue

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_894161471

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

About this item

Full title

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

Publisher

Berlin/Heidelberg: Springer-Verlag

Journal title

Cancer chemotherapy and pharmacology, 2011-10, Vol.68 (4), p.879-887

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer-Verlag

More information

Scope and Contents

Contents

Purpose
Low-dose metronomic (LDM) chemotherapy represents a new strategy to treat solid tumors by stronger antiangiogenic activity and less side effects. The aim of the study is to rationally develop a docetaxel metronomic regimen in preclinical settings of gastric cancer.
Methods
In vitro cell proliferation, apoptosis, and thrombospondin-...

Alternative Titles

Full title

Metronomic docetaxel chemotherapy inhibits angiogenesis and tumor growth in a gastric cancer model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_894161471

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_894161471

Other Identifiers

ISSN

0344-5704

E-ISSN

1432-0843

DOI

10.1007/s00280-011-1563-6

How to access this item